|
Ciclosporin A-binding protein
New method for Medical development against Hepatitis C
Field Health Care, Medicine, Material, Method Keywords Ciclosporin, CSABP, HCV
Abstracts Disclosed are: a composition and a method for the diagnosis and/or the treatment of a CSABP-related disease, the regulation of the proliferation of an RNA virus and the regulation of an RNA-metabolizing system, which targets a cyclosporine A-binding protein (CSABP); a method for the screening of a component that targets a CSABP; a composition and a method for the detection/inhibition of CsA, NS5B or cyclosphilin B by utilizing a CSABP; a promoter for a CSABP; a method for the screening of a substance capable of regulating the expression of a CSABP by utilizing the promoter; and a method for the determination of the occurrence or clinical stage of a CSABP-related disease.
To access the rest of the information on this page, Log In or sign up for a free B-Bridge account:
|